Partnership Will Harness NYSCF’s Automated Cell Culture Systems and Artificial Intelligence Capabilities to Study Disease at an Unprecedented Cellular Level NEW YORK, NY (January 10, 2025)...
Partnership combines advanced cellular tagging with ethnically diverse stem cell lines, addressing critical gaps in biomedical research Seattle, WA and New York, NY – September 4,...
Largest collection of patient stem cell models of multiple sclerosis to date uncovers novel disease insights and opens the door for new treatments NEW YORK, NY...
In her latest op-ed, NYSCF President and CEO Jennifer J. Raab underscores the urgent need for diversity in stem cell research to advance health equity. Discover...
NYSCF mourns the passing of our collaborator, supporter, and friend Jim Simons, who helped us launch many of our impactful programs. “All of us at NYSCF...
As a woman-founded and woman-led organization, advocacy for diversity, equity, inclusion, and belonging (DEIB) is in our DNA. Our founding CEO Susan Solomon always emphasized how...
The International Society for Stem Cell Research (ISSCR) recently announced its 2024 award recipients, with NYSCF – Robertson Stem Cell Investigator Jun Wu, PhD, of UT...
The Context: Brain organoids – 3D avatars of human brain tissue made from stem cells – are a revolutionary tool for studying disease. However, it has...
This week, NYSCF Board member, former interim CEO, and NYSCF – Robertson Stem Cell Investigator Alumnus Derrick Rossi, PhD, was elected to the National Academy of...
The New York Stem Cell Foundation is deeply saddened to learn about the passing of pioneering stem cell research advocate Brooke Ellison this week. Dr. Ellison...
Former Hunter College President Takes Helm of Globally Respected Institute Seeking Cures for Major Diseases Through Stem Cell Science
If you picture where brain disease research takes place, you might conjure an image of a laboratory full of white-coated scientists tinkering with microscopes and pipettes....
The Context: Cell therapies hold enormous promise for treating many of today’s most devastating diseases, but for them to be effective, we have to ensure that...
The Context: Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer deaths in the US, and is one of the most untreatable and lethal...
The Context: Scientists know that our risk for developing highly fatal blood cancers called ‘myeloid malignancies’ (such as acute myeloid leukemia) can be partially determined by...
Even though modern medicine can now cure or alleviate many conditions that killed people only decades ago, the reality is that we have only gotten better...
2023 was an exciting year for science at NYSCF, with many compelling breakthroughs moving toward the clinic and promising strides in our education and outreach efforts....
The Context: Why is it that sometimes you feel a desperate need for a salty snack, and other times you can’t think of anything worse? Your...
2023 was a banner year for the field of stem cells and regenerative medicine. Here is a countdown of some of the biggest, boldest breakthroughs from...
The Context: Glia – the brain’s helper cells – are often overlooked in disease research, but are known to play both supportive roles for neurons, and...
In an exciting step towards a new treatment, an FDA panel has approved a therapy for sickle cell disease that employs CRISPR gene editing. The decision...
When it comes to clinical trials, current drugs are flunking out at alarming rates. Only one in ten will graduate and make it to patients. The...
NYSCF – Robertson Stem Cell Investigator Alumnus Paul Tesar, DPhil, and NYSCF – Druckenmiller Fellow Marissa Scavuzzo, PhD, of Case Western Reserve University are determined to...
Last week we hosted the 18th annual NYSCF Conference at The Rockefeller University, gathering over 500 international participants from academia, industry, government and nonprofits to engage...
